Charles Schwab
CELU icon

Charles Schwab’s Celularity CELU Stock Holding History

Charles Schwab’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,736
Closed -$14.6K – 3583
2023
Q2 		$14.6K Sell
2,736
-14,703
-84% -$94.2K ﹤0.01% 3585
2023
Q1 		$108K Hold
17,439
– – ﹤0.01% 3239
2022
Q4 		$225K Sell
17,439
-129
-0.7% -$2.38K ﹤0.01% 3164
2022
Q3 		$406K Buy
17,568
+14,145
+413% +$429K ﹤0.01% 3060
2022
Q2 		$117K Buy
+3,423
New +$278K ﹤0.01% 3275

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab's CELU Position: Q3 2023 in Review

Charles Schwab sold out of Celularity (CELU) in Q3 2023, closing a stake of 2,736 shares — an estimated $14.6K sold.

Charles Schwab first reported a position in CELU in Q2 2022 and held it in 5 quarters. The position peaked at $406K in Q3 2022. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

  • Charles Schwab reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 2,736 Celularity shares in Q3 2023, an estimated $14.6K.
  • Charles Schwab first reported a position in Celularity in Q2 2022 and held it in 5 quarters.
  • Charles Schwab's Celularity position peaked at $406K in Q3 2022.
  • 45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.